Prestige Consumer Healthcare Profit Margin

Prestige Consumer Healthcare posts a profit margin of 13.29% as of September 2026. That compares with 18.08% in the prior-year period — down 26.5% year over year. That is below the Healthcare sector average of 19.13%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Prestige Consumer Healthcare's profit margin was 18.08%. The latest reading is 13.29% — a 26.5% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 19.13% is typical. Prestige Consumer Healthcare's 13.29% is lower that level. That is roughly 30.5% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Prestige Consumer Healthcare's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 13.29% as of September 2026; use YoY and peer views to separate noise from signal.

Context for PBH's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.13%), and (3) consistency with growth and profitability. This page covers the first two; Prestige Consumer Healthcare's other metric pages and overview cover the third.